Showing 71-80 of 4044 results for "".
Journal Club: Tapinarof Cream in Pediatric Patients
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-tapinarof-cream-in-pediatric-patients/32399/Practical Dermatology Editorial Board member Peter Lio, MD, speaks with Mona Shahriari, MD, about the Journal of Dermatology article "A phase 2, randomized, double-blind, vehicle-controlled trial of tapinarof cream in Japanese pediatric patients with atopic dermatitis," and the general importance ofPDT: Patient Profiles for a Practice-changing Treatment
https://practicaldermatology.com/series/pdt-in-practice/pdt-patient-profiles-for-a-practice-changing-treatment/20186/Who's the ideal candidate for PDT? Other options, limitations? The advances in PDT both doctors and patients would like to see are described by Corey Hartman, MD, who shares his experiences and relates how PDT has improved his practice.Patient Assessment: A Key to AD Care
https://practicaldermatology.com/topics/atopic-dermatitis/patient-assessment-a-key-to-ad-care/19889/What is the Quality of Care in Atopic Dermatitis initiative, and why is it important? Dr. Stephan Weidinger shares his thoughts on the importance of this "impressive" program and offers suggestions to improve the assessment and care of patents with eczema.ILUMYA SUPPORT™ patient access for commercial and Medicare Part B patients
https://practicaldermatology.com/topics/psoriasis/ilumya-support-patient-access-for-commercial-and-medicare-part-b-patients/19860/ILUMYA SUPPORT™ offers comprehensive programs and services to help patients start and stay on therapy with ILUMYA™. Learn about the three main patient access programs offered by ILUMYA SUPPORT™: the Early Access Program, the Co-pay Program, and the Patient Assistance Program. ILUMYA™ is reimbursed uHow Do You Manage the Aesthetic Patient?
https://practicaldermatology.com/topics/practice-management/how-do-you-manage-the-aesthetic-patient/18775/Managing the aesthetic patient is all about building relationships explains Joel L. Cohen, MD, founder of AboutSkin Dermatology in Englewood, CO. Dr. Cohen speaks with host Adam Friedman, MD, Associate Professor of Dermatology, Director, Residency Program, and Director, Translational Research at ThePatient Surveys: When and Why
https://practicaldermatology.com/topics/practice-management/patient-surveys-when-and-why/19112/Todd E. Schlesinger, MD, discusses the benefits of patient surveys and offers tips to get the most out of surveys. Sometimes negative survey responses offer value to the practice--if you use the feedback to improve. Coverage from Vegas Cosmetic Surgery 2014.How to Discuss Isotretinoin’s Safety Profile With Acne Patients
https://practicaldermatology.com/conferences/maui-derm-2024/how-to-discuss-isotretinoins-safety-profile-with-acne-patients/20237/Acne Symposium moderator Guy Webster, MD, PhD, clinical professor of dermatology at Thomas Jefferson University, explains how he helps adolescent patients with the most severe cases of acne manage the potential side effects of isotretinoin.Managing Patients with Atypical Nevi and Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/managing-patients-with-atypical-nevi-and-melanoma/19982/Monitoring patients with several atypical nevi who are at high risk for melanoma is very challenging. Steven Q. Wang, MD offers tips for improving diagnostic accuracy and discusses the role of dermoscopy in detecting melanoma as well as non-melanoma skin cancers at much earlier rates.Patients types that may be a great fit for ILUMYA™
https://practicaldermatology.com/topics/psoriasis/patients-types-that-may-be-a-great-fit-for-ilumya/19859/See how ILUMYA™ is a treatment option for a diverse range of patients with moderate-to-severe plaque psoriasis, including bio-naive and bio-experienced patients, and those aged 65 years or older.Atopic Dermatitis: Rethinking the “Typical” Patient
https://practicaldermatology.com/topics/atopic-dermatitis/atopic-dermatitis-rethinking-the-typical-patient/19666/It's possible to make generalities about the experience of atopic dermatitis, but it's increasingly clear that there is no "typical" patient. Zelma Chiesa Fuxench, MD discusses the latest findings on the signs and symptoms of AD and the populations affected.